Clostridium difficile toxins:: Mechanism of action and role in disease

被引:841
作者
Voth, DE [1 ]
Ballard, JD [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA
关键词
D O I
10.1128/CMR.18.2.247-263.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As the leading cause of hospital-acquired diarrhea, Clostridium difficile colonizes the large bowel of patients undergoing antibiotic therapy and produces two toxins, which cause notable disease pathologies. These two toxins, TcdA and TcdB, are encoded on a pathogenicity locus along with negative and positive regulators of their expression. Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine, which lies within the effector-binding loop and coordinates a divalent cation critical to binding GTP. By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell. TcdA elicits effects primarily within the intestinal epithelium, while TcdB has a broader cell tropism. Important advances in the study of these toxins have been made in the past 15 years, and these are detailed in this review. The domains, subdomains, and residues of these toxins important for receptor binding and enzymatic activity have been elegantly studied and are highlighted herein. Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells. Collectively, the present review provides a comprehensive update on TcdA and TcdBs mechanism of action as well as the role of these toxins in disease.
引用
收藏
页码:247 / +
页数:18
相关论文
共 189 条
[1]   Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A [J].
Aboudola, S ;
Kotloff, KL ;
Kyne, L ;
Warny, M ;
Kelly, EC ;
Sougioultzis, S ;
Giannasca, PJ ;
Monath, TP ;
Kelly, CP .
INFECTION AND IMMUNITY, 2003, 71 (03) :1608-1610
[2]  
ADAMSON P, 1992, J BIOL CHEM, V267, P20033
[3]   Bacterial toxins block endothelial wound repair - Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells [J].
Aepfelbacher, M ;
Essler, M ;
Huber, E ;
Sugai, M ;
Weber, SC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) :1623-1629
[4]  
al-Barrak A, 1999, Can Commun Dis Rep, V25, P65
[5]   Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea [J].
Alfa, MJ ;
Kabani, A ;
Lyerly, D ;
Moncrief, S ;
Neville, LM ;
Al-Barrak, A ;
Harding, GKH ;
Dyck, B ;
Olekson, K ;
Embil, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2706-2714
[6]   OCCURRENCE OF TOXIN-PRODUCING CLOSTRIDIUM-DIFFICILE IN ANTIBIOTIC-ASSSOCIATED DIARRHEA IN SWEDEN [J].
ARONSSON, B ;
MOLLBY, R ;
NORD, CE .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1981, 170 (01) :27-35
[7]   Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France [J].
Barbut, F ;
Lalande, V ;
Burghoffer, B ;
Thien, HV ;
Grimprel, E ;
Petit, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2079-2083
[8]   NUCLEOTIDE-SEQUENCE OF CLOSTRIDIUM-DIFFICILE TOXIN-B GENE [J].
BARROSO, LA ;
WANG, SZ ;
PHELPS, CJ ;
JOHNSON, JL ;
WILKINS, TD .
NUCLEIC ACIDS RESEARCH, 1990, 18 (13) :4004-4004
[9]   Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells [J].
Barth, H ;
Pfeifer, G ;
Hofmann, F ;
Maier, E ;
Benz, R ;
Aktories, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10670-10676
[10]  
BARTLETT JG, 1980, GASTROENTEROLOGY, V78, P431